Our Research Publications
Updated August 2025
Pagination
- Previous page
- Page 55
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Adverse reactions reporting | Chargé S, Young D | 2018 | Blood.ca website | View Adverse reactions reporting | Health care providers | Other |
Initial flow cytometric evaluation of the Clearllab lymphoid screen | Hedley BD, Cheng G, Luider J, Kern W, Lozanski G, Chin-Yee I, Lowes LE, Keeney M, Careaga D, Magari R, Tejidor L | 2018 | Cytometry B Clin Cytom | View Initial flow cytometric evaluation of the Clearllab lymphoid screen | Researchers | Basic research |
Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review | Kjaer M, Bertrand G, Bakchoul T, Massey E, Baker JM, Lieberman L, Tanael S, Greinacher A, Murphy MF, Arnold DM, Baidya S, Bussel J, Hume H, Kaplan C, Oepkes D, Ryan G, Savoia H, Shehata N, Kjeldsen-Kragh J, International Collaboration for Transfusion Medicine Guidelines | 2018 | Vox Sang | View Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review | Researchers | Clinical research |
Clinical Outcomes and Red Blood Cell Storage | Ning S, Heddle NM | 2018 | Hematologic Challenges in the Critically Ill | View Clinical Outcomes and Red Blood Cell Storage | Other | Other |
Les concentrés de facteurs de coagulation | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Les concentrés de facteurs de coagulation | Health care providers | Other |
Hemostatic efficacy of pathogen-inactivated versus untreated platelets: a randomized controlled trial | van der Meer PF, Ypma PF, van Geloven N, van Hilten JA, van Wordragen-Vlaswinkel RJ, Eissen O, Zwaginga JJ, Trus M, Beckers EAM, te Boekhorst P, Tinmouth A, Lin Y, Hsia C, Lee D, Norris PJ, Goodrich RP, Brand A, Hervig T, Heddle NM, van der Bom JG, Kerkhoffs J-LH | 2018 | Blood | View Hemostatic efficacy of pathogen-inactivated versus untreated platelets: a randomized controlled trial | Researchers | Clinical research |
Modeling rare blood in Canada | Blake JT, Clarke G | 2018 | Transfusion | View Modeling rare blood in Canada | Health care providers | New or improved product or process |
Serpin Phage Display: The Use of a T7 System to Probe Reactive Center Loop Libraries with Different Serine Proteinases | de Souza LR, Scott BM, Bhakta V, Donkor DA, Perruzza DL, Sheffield WP | 2018 | Serpins: Methods and Protocols | View Serpin Phage Display: The Use of a T7 System to Probe Reactive Center Loop Libraries with Different Serine Proteinases | Researchers | Other |
Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Health care providers | Benchmarking and standard setting |
Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials | Linkins L, Hu G, Warkentin TE | 2018 | Res Pract Thromb Haemost | View Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials | Researchers | Clinical research |
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss | Sheffield WP, Eltringham-Smith LJ, Bhakta V | 2018 | BMC Biotechnol | View A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss | Researchers | Basic research |
Current practices in perioperative blood management for patients undergoing liver resection: a survey of surgeons and anesthesiologists | Bennett S, Ayoub A, Tran A, English S, Tinmouth A, McIsaac DI, Fergusson D, Martel G | 2018 | Transfusion | View Current practices in perioperative blood management for patients undergoing liver resection: a survey of surgeons and anesthesiologists | Health care providers | Clinical research |
Routine screening method for microparticles in platelet transfusions | Millar D, Murphy L, Labrie A, Maurer-Spurej E | 2018 | J Vis Exp | View Routine screening method for microparticles in platelet transfusions | Health care providers | New or improved product or process |
Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score | Balitsky AK, Kelton JG, Arnold DM | 2018 | Blood | View Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score | Researchers | New or improved product or process |
Focusing in on use of pharmacokinetic profiles in routine hemophilia care | Croteau SE, Callaghan MU, Davis J, Dunn AL, Guerrera M, Khan O, Neufeld EJ, Raffini LJ, Recht M, Wang M, Iorio A | 2018 | Res Pract Thromb Haemost | View Focusing in on use of pharmacokinetic profiles in routine hemophilia care | Health care providers | Clinical research |
Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project | Iorio A, Skinner MW, Clearfield E, Messner D, Pierce GF, Witkop M, Tunis S | 2018 | Haemophilia | View Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project | Health care providers | Clinical research |
The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2 | Lemay A-S, Tong TN, Branch DR, Huang M, Sumner C, Oldfield L, Hawes J, Cserti-Gazdewich CM, Lau W | 2018 | Transfusion | View The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2 | Researchers | Clinical research |
Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial | Pai M, Adhikari NKJ, Ostermann M, Heels-Ansdell D, Douketis JD, Skrobik Y, Qushmaq I, Meade M, Guyatt G, Geerts W, Walsh MW, Crowther MA, Friedrich JO, Burry L, Bellomo R, Brandao da Silva N, Costa Filho R, Cox MJ, Alves Silva S, Cook DJ, on behalf of the PROTECT Investigators | 2018 | PLoS One | View Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial | Researchers | Clinical research |
Ultraviolet-based pathogen inactivation systems: untangling the molecular targets activated in platelets | Schubert P, Johnson L, Marks DC, Devine DV | 2018 | Front Med | View Ultraviolet-based pathogen inactivation systems: untangling the molecular targets activated in platelets | Researchers | Basic research |
Intravenous immune globulin to prevent heparin-induced thrombocytopenia | Warkentin TE, Climans TH, Morin P-A | 2018 | N Engl J Med | View Intravenous immune globulin to prevent heparin-induced thrombocytopenia | Health care providers | Other |
Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Carter RLR, Talbot K, Hur WS, Meixner SC, Van Der Gugten JG, Holmes DT, Côté HCF, Kastrup CJ, Smith TW, Lee AYY, Pryzdial ELG | 2018 | J Thromb Haemost | View Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Health care providers | Basic research |
The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations | Kavsak PA, Ainsworth C, Arnold DM, Scott T, Clark L, Ivica J, Mackett K, Whitlock R, Worster A | 2018 | Clin Biochem | View The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations | Researchers | Basic research |
Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture | Nagao M, Sengupta J, Diaz-Dussan D, Adam M, Wu M, Acker J, Ben R, Ishihara K, Zeng H, Miura Y, Narain R | 2018 | ACS Appl Bio Mater | View Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture | Researchers | Basic research |
Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers | Visram A, Bredeson C, Allan D, Sabloff M, Huebsch L, Tay J, Kekre N, McDiarmid S, Mallick R, Tinmouth A, Martin L, Hamelin L, Maze D | 2018 | Blood Cancer J | View Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers | Health care providers | Clinical research |
Assignment of cytomegalovirus infection status in infants awaiting solid organ transplant: Viral detection methods as adjuncts to serology | Burton CE, Dragan T, Mabilangan CA, O'Brien SF, Fearon M, Scalia V, Preiksaitis JK | 2018 | Pediatr Transplant | View Assignment of cytomegalovirus infection status in infants awaiting solid organ transplant: Viral detection methods as adjuncts to serology | Health care providers | Clinical research |
Improving Time to Antibiotics for Pediatric Oncology Patients With Fever and Suspected Neutropenia by Applying Lean Principles | Geerlinks AV, Digout C, Bernstein M, Chan A, MacPhee S, Pambrun C, Gallant G, Wyatt L, Fernandez CV, Price VE | 2018 | Pediatric Emergency Care | View Improving Time to Antibiotics for Pediatric Oncology Patients With Fever and Suspected Neutropenia by Applying Lean Principles | Researchers | New or improved product or process |
Questioning some recommendations in the umbilical cord blood guideline | Elmoazzen H, Petraszko T | 2018 | J Obstet Gynaecol Can | View Questioning some recommendations in the umbilical cord blood guideline | Health care providers | New or improved product or process |
More than one way to enhance bacterial detection in platelet components | Kamel H, Goldman M | 2018 | Transfusion | View More than one way to enhance bacterial detection in platelet components | Other | New or improved product or process |
ResearchUnit: A model for change: predicting the impact of system-wide improvements | Blake J | 2018 | Blood.ca website | View ResearchUnit: A model for change: predicting the impact of system-wide improvements | Other | New or improved product or process |
rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and Fc?Rs | Spirig R, Campbell IK, Koernig S, Chen C-G, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Kaesermann F, Zuercher AW | 2018 | J Immunol | View rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and Fc?Rs | Researchers | Basic research |
Acquired factor XIII deficiency: A review | Yan MTS, Rydz N, Goodyear D, Sholzberg M | 2018 | Transfus Apher Sci | View Acquired factor XIII deficiency: A review | Researchers | Other |
Screening of red blood cells for extracellular vesicle content as a product quality indicator | Acker JP, Almizraq RJ, Millar D, Maurer-Spurej E | 2018 | Transfusion | View Screening of red blood cells for extracellular vesicle content as a product quality indicator | Researchers | New or improved product or process |
Anti-M (French) | Clarke G, Cote J, Lane D | 2018 | Blood.ca website | View Anti-M (French) | Researchers | Basic research |
Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Langlois GP, Arnold DM, Potts J, Leber B, Dale DC, Mackey MC | 2018 | Clin Case Rep | View Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Health care providers | Clinical research |
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Qu M, Liu Q, Zhao H-G, Peng J, Ni H, Hou M, Jansen AJG | 2018 | Ann Hematol | View Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Health care providers | Clinical research |
Pathogen reduction technologies: The pros and cons for platelet transfusion | Magron A, Laugier J, Provost P, Boilard E | 2018 | Platelets | View Pathogen reduction technologies: The pros and cons for platelet transfusion | Blood operators | Basic research |
ResearchUnit: A different way to look at red blood cell quality | Acker J | 2018 | Blood.ca website | View ResearchUnit: A different way to look at red blood cell quality | Researchers | Clinical research |
Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections | Charlton CL, Babady E, Ginocchio CC, Hatchette TF, Jerris RC, Li Y, Loeffelholz M, McCarter YS, Miller MB, Novak-Weekley S, Schuetz AN, Tang Y-W, Widen R, Drews SJ | 2018 | Clin Microbiol Rev | View Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections | Health care providers | Clinical research |
Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia | Huynh A, Arnold DM, Kelton JG, Smith JW, Horsewood P, Clare R, Guarné A, Nazy I | 2018 | J Thromb Haemost | View Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia | Researchers | Basic research |
IVIg and LPS Co-stimulation Induces IL-10 Production by Human Monocytes, Which Is Compromised by an FcgRIIA Disease-Associated Gene Variant | Kozicky LK, Menzies SC, Zhao ZY, Vira T, Harnden K, Safari K, Del Bel KL, Turvey SE, Sly LM | 2018 | Front Immunol | View IVIg and LPS Co-stimulation Induces IL-10 Production by Human Monocytes, Which Is Compromised by an FcgRIIA Disease-Associated Gene Variant | Researchers | Basic research |
What's in a name? Patient registration errors and their threat to transfusion safety | Ning S, Yan MTS, Downie H, Callum J | 2018 | Transfusion | View What's in a name? Patient registration errors and their threat to transfusion safety | Researchers | New or improved product or process |
Hemostatic Disorders and Hereditary Angioedema | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Clinical Guide to Transfusion | View Hemostatic Disorders and Hereditary Angioedema | Health care providers | Other |
Raman spectroscopy of stored red blood cell concentrate within sealed transfusion blood bags | Vardaki MZ, Atkins CG, Schulze HG, Devine DV, Serrano K, Blades MW, Turner RFB | 2018 | Analyst | View Raman spectroscopy of stored red blood cell concentrate within sealed transfusion blood bags | Researchers | New or improved product or process |
ResearchUnit: Patient blood group impacts susceptibility to IVIg-associated hemolysis | Branch D | 2018 | Blood.ca website | View ResearchUnit: Patient blood group impacts susceptibility to IVIg-associated hemolysis | Researchers | Basic research |
A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study | Del Fiol G MM, Iorio A, Cotoi C, Haynes RB | 2018 | J Med Internet Res | View A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study | Researchers | Clinical research |
Circular of information for the use of human blood components: Platelets | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
Aphérèse thérapeutique | Pavenski K | 2018 | Guide de la pratique transfusionnelle | View Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies | Shih AW, Liu A, Elsharawi R, Crowther MA, Cook RJ, Heddle NM | 2018 | Transfusion | View Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies | Researchers | Clinical research |
Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Wong PPC, Kariminia A, Jones D, Eaves CJ, Foley R, Ivison S, Couban S, Schultz KR | 2018 | Blood | View Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Health care providers | Clinical research |
Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | de Wit K | 2018 | CanadiEM website | View Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | Health care providers | Benchmarking and standard setting |